Company intelligence / Profile preview

ChaoDain Investment Management

Hangzhou, Zhejiang, China

Ownership: Private
Development stage: Other

Overview

ChaoDain (Hangzhou) Investment Management is described in at least one transaction document as an investment firm providing a CHF 1.5m convertible loan to Kinarus Therapeutics, a biotech company, but there is no evidence that it develops drugs or runs clinical programs itself.

Industry: Investors

Partnerships

Provided a CHF 1.5m convertible loan financing to Kinarus Therapeutics (KIN001 program) as part of a broader collaboration/financing framework.

Beyond the preview

Go deeper on ChaoDain Investment Management.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ChaoDain Investment Management.

Explore the full profile